Rom Leidner

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (5)

R. Bryan Bell

UNITED STATES

View details

Keun-Wook Lee

Seoul National University Hospital

SOUTH KOREA

View details

Yoshinobu Koguchi

Associate Professor (Research)

Ohio State University

UNITED STATES

View details

David S. Hong

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Eric Tran

National Institutes of Health

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Rom Leidner

Research Interests

Explore related searches

Contact this professor

Articles (10)

Cancer's Dark Matter: Lighting the Abyss Unveils Universe of New Therapies

Mogamulizumab in Combination with Nivolumab in a Phase I/II Study of Patients with Locally Advanced or Metastatic Solid Tumors

Neoadjuvant nivolumab for patients with resectable HPV-positive and HPV-negative squamous cell carcinomas of the head and neck in the CheckMate 358 trial

Neoadjuvant immunoradiotherapy results in high rate of complete pathological response and clinical to pathological downstaging in locally advanced head and neck squamous cell carcinoma

Enhancing clinical and immunological effects of anti-PD-1 with belapectin, a galectin-3 inhibitor

Neoadjuvant anti-OX40 (MEDI6469) therapy in patients with head and neck squamous cell carcinoma activates and expands antigen-specific tumor-infiltrating T cells

Safety and Clinical Activity of MEDI0562, a Humanized OX40 Agonist Monoclonal Antibody, in Adult Patients With Advanced Solid Tumors.

Transoral robotic surgery and neck dissection for HPV-positive oropharyngeal carcinoma: Importance of nodal count in survival.

First-In-Human Study of Cemiplimab Alone or in Combination with Radiotherapy and/or Low-dose Cyclophosphamide in Patients with Advanced Malignancies

Safety and efficacy of durvalumab and tremelimumab alone or in combination in patients with advanced gastric and gastroesophageal junction adenocarcinoma

Collaborators (5)

R. Bryan Bell

Keun-Wook Lee

Yoshinobu Koguchi

David S. Hong

Eric Tran

Make your next move.